YF-VAX 1 dose vials
Ended Awarded
- Contract number
- SPE2DR26FQGX0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,341
Award facts
- Contract value 100% obligated
- $3,340.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,340.56 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in one-dose vials. The contract, designated as a firm fixed-price delivery order with no set-aside designation, is scheduled for completion by November 28, 2025, and was awarded on November 5, 2025. DMS Pharmaceutical Group serves as the prime contractor with no identified subcontractors, and the products will be delivered to Park Ridge, Illinois for use within the federal pharmaceutical supply chain.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $499.999 billion regional prime vendor contract awarded in November 2025 with a completion date of December 31, 2036. The PPV-G GEN V program is part of the broader $30.3 billion DLA pharmaceutical acquisition strategy designed to supply the full range of pharmaceutical products and medical consumables to Department of Defense military healthcare facilities worldwide. The company's established performance on numerous delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system across multiple therapeutic categories.
Quick answers
Who was awarded contract SPE2DR26FQGX0?
SPE2DR26FQGX0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 5, 2025.
How much is contract SPE2DR26FQGX0 worth?
The government has obligated $3,341 on SPE2DR26FQGX0.
Is contract SPE2DR26FQGX0 an order under another contract?
Yes. SPE2DR26FQGX0 is a delivery order under SPE2DR25D9156, an indefinite delivery contract.
Was contract SPE2DR26FQGX0 competed?
The extent of competition for SPE2DR26FQGX0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award